Tissue distribution study of naringin in rats by liquid chromatography-tandem mass spectrometry
- PMID: 22270844
- DOI: 10.1055/s-0031-1299746
Tissue distribution study of naringin in rats by liquid chromatography-tandem mass spectrometry
Abstract
Naringin (CAS 10236-47-2), a flavanone glucoside widely present in fruits of citrus plants, has received extensive studies on its potential effects on health benefits and was recently demonstrated to be a putative antitussive. In this study, we determined the tissue distributions of naringin and its metabolites (naringenin and naringenin's conjugates) in rats to examine whether they undergo selective uptake by specific organs. Naringin was administered orally to rats at the dose of 42 mg/kg and the concentrations of naringin and its metabolites in tissue compartments were determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS). The areas under curve values in the individual tissues decreased as follows: stomach, small intestine, liver, trachea, muscle, kidney, lung, fat, heart, spleen, ovary, testis, brain for naringin; and liver, stomach, small intestine, kidney, trachea, lung, testis, heart, ovary, fat, spleen, muscle, brain for total naringenin (including free and its conjugates). Naringin and total naringenin were rapidly and widely distributed to all the tissues except brain in rats. They had difficulties in crossing the blood-brain barrier. There are no accumulations in rats. This study identifying naringin in several organs including lung and trachea may explain its effects as antitussive.
© Georg Thieme Verlag KG Stuttgart · New York.
Similar articles
-
Metabolism and excretion studies of oral administered naringin, a putative antitussive, in rats and dogs.Biopharm Drug Dispos. 2012 Apr;33(3):123-34. doi: 10.1002/bdd.1775. Epub 2012 Mar 17. Biopharm Drug Dispos. 2012. PMID: 22374702
-
A rapid LC/MS/MS quantitation assay for naringin and its two metabolites in rats plasma.J Pharm Biomed Anal. 2006 Feb 13;40(2):454-9. doi: 10.1016/j.jpba.2005.07.031. Epub 2006 Jan 10. J Pharm Biomed Anal. 2006. PMID: 16406442
-
Toxicokinetics of naringin, a putative antitussive, after 184-day repeated oral administration in rats.Environ Toxicol Pharmacol. 2011 May;31(3):485-9. doi: 10.1016/j.etap.2011.01.006. Epub 2011 Feb 4. Environ Toxicol Pharmacol. 2011. PMID: 21787720
-
A Review on the Pharmacokinetic Properties of Naringin and Its Therapeutic Efficacies in Respiratory Diseases.Mini Rev Med Chem. 2020;20(4):286-293. doi: 10.2174/1389557519666191009162641. Mini Rev Med Chem. 2020. PMID: 32134369 Review.
-
Naringin: Nanotechnological Strategies for Potential Pharmaceutical Applications.Pharmaceutics. 2023 Mar 7;15(3):863. doi: 10.3390/pharmaceutics15030863. Pharmaceutics. 2023. PMID: 36986723 Free PMC article. Review.
Cited by
-
Assessment of the feed additive consisting of naringin for all animal species for the renewal of its authorisation (HealthTech Bio Actives, S.L.U. (HTBA)).EFSA J. 2022 Apr 22;20(4):e07267. doi: 10.2903/j.efsa.2022.7267. eCollection 2022 Apr. EFSA J. 2022. PMID: 35615734 Free PMC article.
-
Characterization, in Vitro and in Vivo Evaluation of Naringenin-Hydroxypropyl-ß-Cyclodextrin Inclusion for Pulmonary Delivery.Molecules. 2020 Jan 28;25(3):554. doi: 10.3390/molecules25030554. Molecules. 2020. PMID: 32012911 Free PMC article.
-
A Polymethionine Nanoparticle Fluorescent Probe for Sensitive Detection of Naringin and Naringenin.Materials (Basel). 2024 Aug 7;17(16):3919. doi: 10.3390/ma17163919. Materials (Basel). 2024. PMID: 39203099 Free PMC article.
-
Safety and efficacy of a feed additive consisting of a flavonoid-rich dried extract of Citrus × aurantium L. fruit (bitter orange extract) for use in all animal species (FEFANA asbl).EFSA J. 2021 Jul 27;19(7):e06709. doi: 10.2903/j.efsa.2021.6709. eCollection 2021 Jul. EFSA J. 2021. PMID: 34335921 Free PMC article.
-
Aerosolization Performance, Antitussive Effect and Local Toxicity of Naringenin-Hydroxypropyl-β-Cyclodextrin Inhalation Solution for Pulmonary Delivery.AAPS PharmSciTech. 2021 Jan 3;22(1):20. doi: 10.1208/s12249-020-01889-5. AAPS PharmSciTech. 2021. PMID: 33389225
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources